Tivic Health Systems, Inc.
TIVC
$2.09
-$0.58-21.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -49.63% | -58.49% | -54.50% | -33.67% | -22.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -49.63% | -58.49% | -54.50% | -33.67% | -22.00% |
| Cost of Revenue | 7.17% | -31.13% | -20.43% | -12.49% | -21.18% |
| Gross Profit | -213.82% | -129.35% | -133.72% | -99.30% | -24.31% |
| SG&A Expenses | -6.06% | -21.15% | -35.08% | -35.87% | -22.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.71% | -12.56% | -28.39% | -30.99% | -22.20% |
| Operating Income | -16.26% | 4.99% | 24.49% | 30.61% | 22.22% |
| Income Before Tax | -16.90% | 6.06% | 25.40% | 31.40% | 22.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.90% | 6.06% | 25.40% | 31.40% | 22.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.90% | 6.06% | 25.40% | 31.40% | 22.22% |
| EBIT | -16.26% | 4.99% | 24.49% | 30.61% | 22.22% |
| EBITDA | -16.32% | 4.98% | 24.46% | 30.58% | 22.20% |
| EPS Basic | 81.06% | 83.90% | 92.09% | 91.56% | 83.93% |
| Normalized Basic EPS | 81.05% | 83.73% | 92.02% | 91.53% | 83.93% |
| EPS Diluted | 81.06% | 83.90% | 92.09% | 91.56% | 83.93% |
| Normalized Diluted EPS | 81.05% | 83.73% | 92.02% | 91.53% | 83.93% |
| Average Basic Shares Outstanding | 321.69% | 381.00% | 536.51% | 517.20% | 678.55% |
| Average Diluted Shares Outstanding | 321.69% | 381.00% | 536.51% | 517.20% | 678.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |